Treatment of alopecia areata with squaric acid dibutylester

被引:21
作者
Hill, Nikki D. [1 ]
Bunata, Kristin [2 ]
Hebert, Adelaide A. [1 ]
机构
[1] Univ Texas Houston, Hlth Sci Ctr, Dept Dermatol, Houston, TX 77030 USA
[2] Univ Texas Houston, Sch Med, Houston, TX 77030 USA
关键词
CLASS-I EXPRESSION; TOPICAL IMMUNOTHERAPY; DIPHENYLCYCLOPROPENONE; DINITROCHLOROBENZENE; THERAPY; SKIN;
D O I
10.1016/j.clindermatol.2014.12.001
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Squaric acid dibutylester is a topical sensitizing agent utilized for the treatment of alopecia areata. The mechanism of action is not fully understood, but is believed to redirect the inflammatory response by invoking allergic contact dermatitis. Several studies have compared the efficacy of squaric acid dibutylester to other treatments vs placebo with favorable results. This contribution reviews the history of the topical sensitizing agent squaric acid dibutylester and discusses the mechanism of action, the use in alopecia areata, and the efficacy and safety of this therapeutic agent. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:300 / 304
页数:5
相关论文
共 34 条
[1]  
Ajith C, 2006, J Drugs Dermatol, V5, P262
[2]  
AVELLA J, 1978, LANCET, V1, P624
[3]   ABNORMAL EXPRESSION OF CLASS-I AND CLASS-II MAJOR HISTOCOMPATIBILITY ANTIGENS IN ALOPECIA-AREATA - MODULATION BY TOPICAL IMMUNOTHERAPY [J].
BROCKER, EB ;
ECHTERNACHTHAPPLE, K ;
HAMM, H ;
HAPPLE, R .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1987, 88 (05) :564-568
[4]   TOPICAL THERAPY OF ALOPECIA-AREATA WITH SQUARIC ACID DIBUTYLESTER [J].
CASE, PC ;
MITCHELL, AJ ;
SWANSON, NA ;
VANDERVEEN, EE ;
ELLIS, CN ;
HEADINGTON, JT .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1984, 10 (03) :447-451
[5]   TREATMENT OF ALOPECIA-AREATA WITH SQUARIC ACID DIBUTYLESTER [J].
CASERIO, RJ .
ARCHIVES OF DERMATOLOGY, 1987, 123 (08) :1036-1041
[6]  
D'Ovidio R, 1995, GIORN ITAL DERMAT V, V295, P130
[7]   Topical immunomodulator therapy with squaric acid dibutylester (SADBE) is effective treatment for severe alopecia areata (AA): Results of an open-label, paired-comparison, clinical trial [J].
Dall'Oglio, F ;
Nasca, MR ;
Musumeci, ML ;
La Torre, G ;
Ricciardi, G ;
Potenza, C ;
Micali, G .
JOURNAL OF DERMATOLOGICAL TREATMENT, 2005, 16 (01) :10-14
[8]   TREATMENT OF ALOPECIA-AREATA WITH DINITROCHLOROBENZENE [J].
DAMAN, LA ;
ROSENBERG, EW ;
DRAKE, L .
ARCHIVES OF DERMATOLOGY, 1978, 114 (07) :1036-1038
[9]   Dinitrochlorobenzene is genotoxic by sister chromatid exchange in human skin fibroblasts [J].
DeLeve, LD .
MUTATION RESEARCH-GENETIC TOXICOLOGY, 1996, 371 (1-2) :105-108
[10]  
Diaz L, 2012, 38 ANN M SOC PED DER